A carregar...

Cell proliferation measured by MIB1 and timing of surgery for breast cancer.

We have investigated the use of the antibody MIB1 as a proliferative and prognostic marker in breast cancer and whether changes in proliferative activity could account for differences in prognosis of premenopausal women operated on during different phases of the menstrual cycle. MIB1 expression was...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Cooper, L. S., Gillett, C. E., Smith, P., Fentiman, I. S., Barnes, D. M.
Formato: Artigo
Idioma:Inglês
Publicado em: Nature Publishing Group 1998
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC2150202/
https://ncbi.nlm.nih.gov/pubmed/9652769
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!